Latest News and Press Releases
Want to stay updated on the latest news?
-
AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute Dans les études de phase 3 COAST 1, COAST 2 et SHORE,...
-
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...
-
Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supporting KT-621’s compelling oral profile Parallel Phase 2b trials, BROADEN2 in atopic dermatitis and...
-
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at 2026 AAD
-
CODE27 Secures Over $10 Million in Funding to Build Immersive Interactive Character Companion Hardware
-
紐約, March 28, 2026 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律師事務所 Rosen Law Firm 提醒在 2024 年 4 月 30 日至 2026 年 1 月 13 日(包括首尾兩日,簡稱「集體訴訟期」)期間購買了 Trip.com Group Limited 證券(NASDAQ:...
-
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Atara...
-
TORONTO, March 28, 2026 (GLOBE NEWSWIRE) -- TitanPlay, a regulated iGaming operator in Ontario’s licensed market, today outlined its responsible gambling framework, emphasizing accessible tools,...
-
Baltimore, MD, March 28, 2026 (GLOBE NEWSWIRE) -- Jim Rickards, the economist and former CIA advisor who has spent five decades at the intersection of Wall Street and Washington, has released a...
-
ROAD TOWN, British Virgin Islands, March 28, 2026 (GLOBE NEWSWIRE) -- TxFlow has announced the launch of its Layer 1 blockchain, TxFlow L1, marking the start of a multi-application on-chain...